Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings

Table 3 Method of notification to the ACIR for 13vPCV supplementary doses from survey respondents (n = 120) and ACIR data at 31 December 2012

	Aboriginal Medical Service		Community Health		General practice		All providers
	Survey data^a% providers	ACIR data^b% doses	Survey data^a% providers	ACIR data^b% doses	Survey data^a% providers	ACIR data^b% doses	Survey data^a% providers	ACIR data^b% doses
Direct transfer from practice management software	40	–	5	2	59	64	47	47
Entered directly onto ACIR secure website	47	100	85	75	27	26	40	39
Paper forms posted to ACIR	13	–	5	23	8	11	8	14
Patient lists faxed to ACIR	–	No data	–	No data	1	No data	1	No data
Telephone direct to ACIR	–	No data	5	No data	5	No data	4	No data

Footnotes
^aSurvey data is the proportion of respondents who indicated they notified supplementary doses of 13vPCV to the ACIR via each notification method.
^bACIR data is the proportion of recorded doses of 13vPCV for each provider in the NNSW and MNC LHDs who notified by each method.

ISSN: 1472-6963